What is being hailed as a ‘cancer treatment breakthrough’ comes not from a brand-new experimental drug, but from a 40-year-old medicine used to treat worms.
Researchers from Johns Hopkins University have patented a new form of mebendazole, called polymorph C, which may work much better against cancer than the versions currently available.
Mebendazole is already a well-known drug that safely treats parasitic worm infections in humans and animals.
The new crystal form, polymorph C, seems to get into tumors more effectively, including brain tumors, which are usually very hard to treat because most drugs cannot pass through the protective blood-brain barrier.
According to the patent, an oral formulation with at least 90 percent polymorph C can reach cancer cells at higher concentrations than standard mebendazole, potentially making it more powerful.